IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 78 filers reported holding IVERIC BIO INC in Q1 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $230,454 | -16.8% | 5,858 | -79.7% | 0.00% | – |
| Q2 2022 | $277,000 | -42.5% | 28,790 | +0.6% | 0.00% | -100.0% |
| Q1 2022 | $482,000 | +0.6% | 28,630 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $479,000 | +3.0% | 28,630 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $465,000 | +36.0% | 28,630 | -47.3% | 0.00% | 0.0% |
| Q2 2021 | $342,000 | +0.9% | 54,275 | -1.2% | 0.00% | 0.0% |
| Q1 2021 | $339,000 | -10.8% | 54,921 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $380,000 | +22.6% | 54,921 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $310,000 | +10.7% | 54,921 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $280,000 | +48.1% | 54,921 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $189,000 | -59.9% | 54,921 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $471,000 | +659.7% | 54,921 | 0.0% | 0.00% | – |
| Q3 2019 | $62,000 | -12.7% | 54,921 | 0.0% | 0.00% | – |
| Q2 2019 | $71,000 | – | 54,921 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 5,339,518 | $210,056,638 | 52.85% |
| Chicago Capital Management, LLC | 359,561 | $14,145,130 | 18.12% |
| TCG Crossover Management, LLC | 2,448,829 | $96,336,933 | 15.80% |
| Vazirani Asset Management LLC | 180,000 | $7,081,200 | 11.94% |
| SYQUANT CAPITAL SAS | 406,686 | $15,999 | 11.62% |
| KRYGER CAPITAL Ltd | 2,523,853 | $99,288,377 | 10.16% |
| MPM BioImpact LLC | 1,214,662 | $47,784,803 | 9.62% |
| FNY Investment Advisers, LLC | 180,106 | $7,085 | 8.98% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 5,850,120 | $230,143,721 | 7.26% |
| HARVEST MANAGEMENT LLC | 213,500 | $8,399,090 | 7.25% |